Luteinizing hormone induction of ovarian tumors: oligogenic differences between mouse strains dictates tumor disposition

Proceedings of the National Academy of Sciences of the United States of America
Ruth A KeriJohn H Nilson

Abstract

The use of fertility drugs has continued to grow since their introduction in the 1960s. Accompanying this increase has been the speculation that repetitive use of these drugs can cause ovarian tumors or cancer. We recently reported that transgenic mice with chronically elevated luteinizing hormone (LH), an analog of which is commonly used in fertility regimens, develop granulosa cell (GC) tumors. In this report we show that LH induction of these tumors is highly dependent on genetic background. In CF-1 mice, chronically elevated LH invariably causes GC tumors by 5 months of age. However, in hybrid mice generated by crossing CF-1 males with C57BL/6, SJL, or CD-1 females, elevated levels of this same hormone cause a completely different phenotype resembling a luteoma of pregnancy. We also show that three genes likely control these alternative hormonal responses. This clinical correlate of elevated LH reveals remarkably distinct, strain-dependent, ovarian phenotypes. In addition, these results support the rare incidence of GC tumors in the human population, and suggest that the ability of certain fertility drugs to cause ovarian tumors may depend on an individual's genetic predisposition.

References

Jan 1, 1981·Annual Review of Biochemistry·J G Pierce, T F Parsons
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·K A RismaJ H Nilson
Sep 22, 1994·The New England Journal of Medicine·M A RossingS G Self
Apr 17, 1993·Lancet·W WillemsenR Rolland
Oct 1, 1996·Fertility and Sterility·R E Bristow, B Y Karlan
Feb 1, 1997·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·P G ArtiniA R Genazzani
Jun 1, 1997·Fertility and Sterility·B J MosgaardA N Andersen
Nov 22, 1997·Biology of Reproduction·J A FlawsA N Hirshfield
Dec 24, 1997·Human Reproduction·F ParazziniP G Crosignani

❮ Previous
Next ❯

Citations

May 20, 2005·Cell and Tissue Research·Barbara C Vanderhyden
Apr 20, 2005·Molecular and Cellular Endocrinology·Ilpo HuhtaniemiMatti Poutanen
Jun 5, 2002·Molecular and Cellular Endocrinology·Peter J FullerHenry G Burger
Apr 27, 2001·Toxicology Letters·M F Festing
Aug 13, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·K D Sloan Stakleff, V E Von Gruenigen
Apr 4, 2003·Biology of Reproduction·Martin M MatzukT Rajendra Kumar
Feb 1, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I Konishi
Apr 17, 2001·Australian Veterinary Journal·R K SivacolundhuR A Read
Apr 19, 2002·Genome Génome / Conseil National De Recherches Canada·Jeong-Soon KimDavid M Stelly
Nov 14, 2003·Reproductive Biology and Endocrinology : RB&E·Barbara C VanderhydenJean-François Ethier
Sep 25, 2009·Endocrine Reviews·Mark A EdsonMartin M Matzuk
Aug 27, 2005·Reproduction : the Official Journal of the Society for the Study of Fertility·Susana B Rulli, Ilpo Huhtaniemi
Jul 19, 2011·Molecular and Cellular Endocrinology·Stephanie A Pangas
Jul 29, 2008·Molecular and Cellular Endocrinology·Ankur K NagarajaMartin M Matzuk
Mar 14, 2007·Molecular and Cellular Endocrinology·Tomi PakarainenIlpo Huhtaniemi
Sep 15, 2011·The Journal of Pathology·Sietske T BakkerHein te Riele
Oct 31, 2006·Biochemical and Biophysical Research Communications·J AravindakshanM R Sairam
Jun 10, 2006·Molecular and Cellular Endocrinology·Brandon M NathanMark R Palmert
Oct 21, 2015·Frontiers in Endocrinology·Prema Narayan
Feb 26, 2013·Cancer Treatment Reviews·Francesca RicciGiovanna Damia
Apr 2, 2010·Journal of Ovarian Research·Allison C SharrowAllan D Hess
Mar 12, 2017·Reproduction : the Official Journal of the Society for the Study of Fertility·Dallas A Vanorny, Kelly E Mayo
Apr 23, 2016·Clinical and Experimental Reproductive Medicine·So-Youn Kim
Jan 12, 2011·Menopause : the Journal of the North American Menopause Society·Laura A LavioletteBarbara C Vanderhyden
Apr 28, 2007·Endocrine Reviews·Jung-Hye ChoiPeter C K Leung
May 30, 2003·American Journal of Physiology. Endocrinology and Metabolism·Jukka T KeroIlpo T Huhtaniemi
Oct 8, 2011·International Journal of Immunopathology and Pharmacology·Manuela IezziF Cavallo
May 27, 2006·Human Reproduction Update·K R BarnettJ A Flaws
Mar 9, 2005·Journal of Neuropathology and Experimental Neurology·Craig S AtwoodRichard L Bowen
Nov 25, 2020·Metabolites·Patrick PannJerzy Adamski
May 22, 2018·Best Practice & Research. Clinical Endocrinology & Metabolism·Sara Babcock GilbertT Rajendra Kumar
Oct 21, 2010·Journal of Ovarian Research·Bridget A QuinnDenise C Connolly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.